Thu, 19th Jul 2007 09:03 LONDON (Thomson Financial) - Telephony company Netcall rose 3 pence to 28-1/2 after it said it
expects full-year profits significantly ahead of market expectations, while revenues are expected to be in line with estimates.
The company said first-half trading for the period to June 30 has progressed according to plan, adding that it looks forward to continued progress.
And ValiRx firmed 0.07 to 0.77 after the cancer therapeutics company said it has signed a memorandum of understanding with Belgian company BIO, to establish a joint venture focused on the epigenomics sector.
tf.TFN-Europe_newsdesk@thomson.com
mnd/ajb
COPYRIGHT
Copyright AFX News Limited 2007. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.